关注
Mariya Korotetskaya
Mariya Korotetskaya
Centeral Institute for Tuberculosis Department Immunology
在 ctri.ru 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells
LS Agapova, BV Chernyak, LV Domnina, VB Dugina, AY Efimenko, ...
Biochemistry (Moscow) 73, 1300-1316, 2008
972008
Mitochondria as source of reactive oxygen species under oxidative stress. Study with novel mitochondria-targeted antioxidants—the “Skulachev-ion” derivatives
DS Izyumov, LV Domnina, OK Nepryakhina, AV Avetisyan, SA Golyshev, ...
Biochemistry (Moscow) 75, 123-129, 2010
782010
Mitochondria-targeted antioxidant SkQR1 selectively protects MDR (Pgp 170)-negative cells against oxidative stress
EK Fetisova, AV Avetisyan, DS Izyumov, MV Korotetskaya, BV Chernyak, ...
FEBS letters 584 (3), 562-566, 2010
512010
The QTL within the H2 Complex Involved in the Control of Tuberculosis Infection in Mice Is the Classical Class II H2-Ab1 Gene
N Logunova, M Korotetskaya, V Polshakov, A Apt
PLoS genetics 11 (11), e1005672, 2015
342015
In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium
BV Nikonenko, A Kornienko, K Majorov, P Ivanov, T Kondratieva, ...
Antimicrobial Agents and Chemotherapy 60 (10), 6422-6424, 2016
182016
Heterogeneity of mitochondrial potential as a marker for isolation of pure cardiomyoblast population
TG Khryapenkova, EY Plotnikov, MV Korotetskaya, GT Sukhikh, DB Zorov
Bulletin of experimental biology and medicine 146, 506-511, 2008
142008
Локус комлекса Н2, участвующий в контроле туберкулёзной инфекции, локализуемый в области генов класса II
ЛНН Коротецкая М. В., Авербах М. М., Апт А. С
Туберкулез и болезни легких, 51-56, 2013
42013
Multidrug resistance p-glycoprotein inhibits antiapoptotic action of mitochondria-targeted antioxidant SkQR1
EK Fetisova, AV Avetisyan, DS Izyumov, MV Korotetskaya, VN Tashlitskii, ...
Cell and Tissue Biology 5, 37-46, 2011
42011
BCG and BCGΔBCG1419c transiently protect hypersusceptible I/St mice and induce different influx of macrophages and neutrophils during pulmonary tuberculosis
M Korotetskaya, P Baikuzina, CA Segura-Cerda, MJ Aceves-Sánchez, ...
Journal of Medical Microbiology 71 (1), 001485, 2022
32022
Efficacy of anti-tuberculosis therapy with INH, RIF and Bedaquiline in mice with different genetic susceptibility to the infection
B Nikonenko, I Bocharova, M Korotetskaya, E Kondratieva, A Apt
European Respiratory Journal 54 (suppl 63), 2019
22019
Analysis of gene expression in the lung tissue in mice congenic as per H2-line complex with various severity of tuberculous infection course
MN Logunova, MV Korotetskaya, AS Apt
Tuberculosis and Lung Diseases, 44-49, 2015
22015
THE COURSE OF TUBERCULOSIS INFECTION IN HYPER-SUSCEPTIBLE MICE CARRYING THE H2V HAPLOTYPE
PG Baikuzina, DV Gorbacheva, AS Apt, MV KOROTETSKAYA
Russian Journal of Immunology, 2024
2024
Inability of the BCG vaccine to protect mice of the H2f haplotype at advanced stages of TB infection is associated with defective CD4+ T-cell activation in spleen
M Korotetskaya, P Baikuzina, A Apt
Tuberculosis 143, 102429, 2023
2023
Metabolic biological markers for diagnosing and monitoring the course of tuberculosis
MV Korotetskaya, EI Rubakova
Russian Journal of Infection and Immunity 12 (5), 827-836, 2022
2022
How effects of BCG vaccination depend upon host genetics: performance of MHC haplotypes in congenic mouse strains B10. M (H2f) and B10 (H2b)
M Korotetskaya, P Baikuzina, A Apt
FEBS OPEN BIO 11, 454-454, 2021
2021
Anti-TB efficacy of PBTZ169 in mice with different genetic susceptibility to infection
B Nikonenko, V Makarov, I Bocharova, M Korotetskaya, E Kondratieva, ...
European Respiratory Journal 56 (suppl 64), 2020
2020
Defective BCG performance against tuberculosis challenge in mice of the B10. M (H2 (f)) strain and immune response to mycobacterial antigens
M Korotetskaya, P Baikuzina, A Apt
EUROPEAN JOURNAL OF IMMUNOLOGY 49, 1663-1663, 2019
2019
Неэффективность вакцины BCG для защиты от туберкулезной инфекции у мышей линии B10. M (H2f) и иммунный ответ на антигены микобактерий
МВ Коротецкая, ПГ Байкузина, АС Апт
Туберкулез и болезни легких 97 (7), 48-55, 2019
2019
Peculiarities of BCG vaccine performance in B10. M (H2f) mice
M Korotetskaya, P Baikuzina, M Kapina, A Apt
FEBS OPEN BIO 8, 197-197, 2018
2018
The H2-Ab1 Class II gene regulates the level of susceptibility and immune responses in the mouse model of tuberculosis infection
M Korotetskaya, A Apt, N Logunova
EUROPEAN JOURNAL OF IMMUNOLOGY 46, 1182-1182, 2016
2016
系统目前无法执行此操作,请稍后再试。
文章 1–20